Organovo

$14.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.40 (+2.86%) Today

$0.00 (0.00%) As of 9:42 PM UTC after-hours

Why Robinhood?

You can buy or sell Organovo and other stocks, options, and ETFs commission-free!

About ONVO

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded in April 2007 and is headquartered in San Diego, CA. The listed name for ONVO is Organovo Holdings, Inc. Common Stock.

CEO

Keith Murphy

Employees

Headquarters

San Diego, California

Founded

2012

Market Cap

90.44M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

428.46K

High Today

$15.37

Low Today

$14.02

Open Price

$14.12

Volume

343.85K

52 Week High

$20.49

52 Week Low

$3.87

Collections

ONVO Earnings

-$1.36

-$0.91

-$0.45

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Feb 18, After Hours